All Neuroscience articles
-
FeatureThe molecular mystery of how we smell
Despite being one of our key senses, the molecular mechanisms of smell remain poorly understood. Mason Wakley sniffs out the competing theories of what may be happening in our noses
-
ResearchLow lithium levels linked to Alzheimer’s
Immune cells’ ability to degrade amyloid-beta peptides restored in mice treated with lithium salt
-
ResearchBlown up brain cells’ connections and chemistry traced at incredible molecular resolution
Microscopy on tissue swollen to 16 times its normal size can help unravel neural structures
-
FeatureWhy don’t we know how antidepressants work yet?
Selective serotonin reuptake inhibitors are at the centre of a collision between social and biochemical outlooks on depression, finds Andy Extance
-
FeatureBypassing the blood–brain barrier
Researchers are on a quest to outsmart and overcome the sophisticated security system of the brain. Julia Robinson reports on some of the approaches being studied
-
FeatureBrain chemistry basics
Andy Extance looks into the latest in Alzheimer’s disease, pain and memory
-
OpinionUnderstanding our brains is complicated, beware of simple ideas
Stepping up from chemistry to complexity
-
OpinionEmmeline Edwards: ‘I connect the dots’
The Haitian-American neurochemist on her journey from Haiti to the US as a teenager, and her journey from chemistry to brain science
-
ResearchNew mechanism identified that is potentially linked to very early stages of Alzheimer’s
Understanding role of fragments of amyloid protein could lead to novel therapies for the disease
-
ResearchCertain household chemicals could pose a threat to brain health, research suggests
Cell and animal tests suggest two classes of common chemicals might play a role in neurological disease
-
FeatureHow microbes influence our brain health
Our gut microbiome has been linked to conditions such as Parkinson’s and Alzheimer’s. Anthony King reports on the connections
-
OpinionFrom one sinking ship to another?
Biogen abandoning Alzheimer’s antibody aducanumab is unusual, but hardly surprising, says Derek Lowe
-
ResearchRare medical transmission of Alzheimer’s disease from donor to patient discovered
Human growth hormone extracted from cadavers passed disease protein to at least five people
-
BusinessPharmaceuticals roundup 2023
Regulatory and pricing reforms have topped industry agendas in 2023, while weight loss drugs surged and Covid-19 therapies waned
-
WebinarOverloaded with author Ginny Smith
Hear from author Ginny Smith about her book Overloaded: how every aspect of your life is influenced by your brain chemicals
-
OpinionMoving beyond protein structure
Efforts to understand how intrinsically disordered regions interact have produced a variety of answers
-
OpinionLetters: September 2023
Readers estimate the contribution of lithium mining on power consumption, consider Alzheimer’s antibody therapies and more
-
BusinessBiogen to cut 1000 more jobs by 2025
Biotech giant has also agreed to buy Reata Pharmaceuticals for $7.3 billion
-
BusinessAntibodies face Alzheimer’s reality
Companies are convincing regulators, but will doctors use them, and will providers pay for them?
-
ResearchTell-tale protein fragment discovered in Alzheimer’s patients could be basis for blood test
Tau protein fragment could track progress of the disease